Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Advertisement
First Tracks Biotherapeutics Inc

First Tracks Biotherapeutics Inc (TRAX) Stock Overview

Explore First Tracks Biotherapeutics Inc’s financial performance, market position, analyst ratings, and future outlook.

TRAX●NASDAQ
HealthcareBiotechnology
$36.16
$3.76(11.60%)
U.S. Market opens in 64h 22m
Advertisement

First Tracks Biotherapeutics Inc (TRAX)

Meyka AI Score

Z

Key Financials

Market Cap1.3B
P/E Ratio-11.52
EPS (TTM)$-4.71
ROE-0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$15.81
3 Months$40.49
1 Year Target$41.05

TRAX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of First Tracks Biotherapeutics Inc (TRAX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 80.23, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $41.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.52 and a market capitalization of 1.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
11.60%
5-Day Change
88.04%
1-Month Change
120.22%
3-Month Change
53.87%
6-Month Change
90.32%
Year-to-Date (YTD) Change
90.32%
1-Year Change
90.32%
3-Year Change
90.32%
5-Year Change
90.32%
All-Time (Max) Change
90.32%

Contact Information

https://www.firsttracksbio.com
858 362 6295
10770 Wateridge Circle, San Diego, CA, 92121

Company Facts

1,040 Employees
IPO DateApr 20, 2026
CountryUS
Actively Trading

Frequently Asked Questions